top of page


News


Israeli MedTech Start-up, Alpha Tau Medical, Raises $29 Million in Private Financing to Cure Cancer
Proceeds to accelerate expansion of global clinical research program and establish new production facilities to meet growing demand for...
Sep 5, 2018


New Radiotherapy Approach Deemed Safe for Clinical Trials
The Massachusetts Radiation Control Program (RCP), in conjunction with the U.S. Nuclear Regulatory Commission (NRC), has approved Alpha...
Aug 23, 2018


Israeli Oncology Company Alpha Tau is Raising Funds
Alpha Tau is in the last stages of raising an investment of several tens of millions of dollars. Israeli oncology company Alpha Tau...
Aug 22, 2018


Alpha Tau’s High-Precision Cancer Radiotherapy Receives Radioactive-Safety Approval in the United St
The new Sealed Source and Device (SSD) approval enables the commencement of clinical trials in leading hospitals across the U.S. with the...
Aug 22, 2018


Israeli Medical Startups Beat a Path to Aging Japan
[..] Another company from Tel Aviv, Alpha Tau Medical, has partnered with Japanese biotechnology startup HekaBio to release radiation...
Aug 22, 2018


CEO Uzi Sofer Reveals Great News on Galatz Radio 02.07.2018
Alpha Tau Medical focuses on research, development and commercialization of Alpha DaRT (Diffusing Alpha-Emitters Radiation Therapy) for...
Jul 15, 2018


חוקרים ישראלים פיתחו אפליקציות לחקר מחלת הסרטן
מאפליקציה של מציאות מדומה שמפחיתה כאב ועד מכשיר כף יד שמציג פתרון לגילוי מאוחר של הסרטן. 4 חברות הציגו בכנס בינלאומי של מדעי החיים מיזמים...
May 22, 2018


10 Breakthrough Health Techs Emerging From Israel
Alpha Tau Medical achieved great results at the Biomed MIXiii startup competition. The Alpha Tau team presented its highly potent and...
May 22, 2018


Alpha Particles Treat Deeper Into Solid Tumors
View article here
May 4, 2018


Manage Your Blog from Your Live Site
We’ve made it quick and convenient for you to manage your blog like a boss! First Publish your site, then login directly to your live...
Apr 10, 2018
bottom of page




















